comparemela.com

Jing Choi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Certain Meds Not Cost-Effective for First-Line Therapy of Type 2 Diabetes

Certain Meds Not Cost-Effective for First-Line Therapy of Type 2 Diabetes
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

United statesJing choiUniversity of chicagoHealthday news

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

The proven cardiovascular benefits of these agents can’t be realized unless prices drop by as much as 90%, researchers say.

United statesJing choiEli lillyNeda laiteerapongSteven marsoEuropean association for the study of diabetesBs university of chicagoMd university of chicagoVascular instituteAmerican diabetes associationNovo nordiskEuropean associationMidwest heartOverland parkPatients out

Certain Meds Not Cost-Effective for First-Line Therapy of T2DM

Compared with metformin, SGLT2 inhibitors, GLP-1 receptor agonists cost more for treatment in drug-naive patients with type 2 diabetes.

United statesJing choiUniversity of chicagoHealthday news

Newer Drugs Not Cost-Effective for First-Line Diabetes Therapy

Costs of SGLT2 inhibitors and GLP-1 receptor agonists need to be lowered substantially to improve health outcomes and prevent health disparities in patients with type 2 diabetes, say researchers.

United statesUniversity of chicagoUnited kingdomJing choiNeda laiteerapongNutrition examination surveyNational healthDrug administrationChronic disease researchMedscape medical newsAffordable insulin now actPrices too highEncourage first lineUnited kingdom prospective diabetes studyOutcomes modelCould remain

vimarsana © 2020. All Rights Reserved.